Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
3.150
+0.120 (3.96%)
At close: Jul 21, 2025, 4:00 PM
3.020
-0.130 (-4.13%)
Pre-market: Jul 22, 2025, 9:00 AM EDT

Celularity Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Celularity.

Price Target: n/a
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for Celularity.

Recommendation Trends

RatingAug '22Sep '22Oct '22Nov '22Dec '22Jan '23
Strong Buy222220
Buy111100
Hold222230
Sell000000
Strong Sell000000
Total555550

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Sell
Downgrades
$50$10
SellDowngrades$50$10+217.46%Jan 30, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$150$25
Strong BuyMaintains$150$25+693.65%Jan 30, 2023
Oppenheimer
Oppenheimer
Hold
Downgrades
n/a
HoldDowngradesn/an/aDec 22, 2022
Morgan Stanley
Morgan Stanley
Hold
Maintains
$80$50
HoldMaintains$80$50+1,487.30%Sep 12, 2022
Alliance Global Partners
Alliance Global Partners
Strong Buy
Initiates
$150
Strong BuyInitiates$150+4,661.90%Aug 25, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
66.85M
from 54.22M
Increased by 23.29%
Revenue Next Year
n/a
from 66.85M
EPS This Year
-0.43
from -2.64
EPS Next Year
n/a
from -0.43
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue
14.28M21.34M17.98M22.77M54.22M66.85M
Revenue Growth
-32.48%49.43%-15.75%26.68%138.11%23.29%
EPS
-113.06-14.930.95-11.02-2.64-0.43
EPS Growth
------
Forward PE
------
No. Analysts
-----3
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025
High68.8M
Avg66.8M
Low64.2M

Revenue Growth

Revenue Growth2025
High
26.9%
Avg
23.3%
Low
18.5%

EPS Forecast

EPS2025
High-0.44
Avg-0.43
Low-0.41

EPS Growth

EPS Growth2025
High-
Avg-
Low-
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.